These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10366067)

  • 1. Dorzolamide-timolol combination versus concomitant administration of its components.
    Odberg T
    Ophthalmology; 1999 Jun; 106(6):1044-5. PubMed ID: 10366067
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A; Pugliese M; De Majo M; Niutta PP; Pugliese A
    Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glaucoma: an ocular blood flow disorder?].
    Recker K
    Ophthalmologe; 2003 Feb; 100(2):2 p following 174. PubMed ID: 12650170
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the efficacy on intraocular pressure and retinal blood flow of a beta-blocker (timolol maleate) against the fixed association of a topical carbonic anhydrase (dorzolamide) and a beta-blocker (timolol maleate).
    Brogliatti B; Rolle T; Vizzeri GM; Cipullo D
    Acta Ophthalmol Scand Suppl; 2000; (232):47-9. PubMed ID: 11235534
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K; Orgül S; Flammer J
    Curr Med Res Opin; 2003; 19(4):330-5. PubMed ID: 12841926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypotensive efficacy of dorzolamide HCL-timolol maleate 0.50% vs concomitant use of the two drugs.
    Durante A; Aurilia P; Guarnaccia G; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 2000; (232):46. PubMed ID: 11235533
    [No Abstract]   [Full Text] [Related]  

  • 9. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of dorzolamide-timolol combination versus the concomitant drugs.
    Choudhri S; Wand M; Shields MB
    Am J Ophthalmol; 2000 Dec; 130(6):832-3. PubMed ID: 11124307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic contact dermatitis from timolol and dorzolamide eye drops.
    Kalavala M; Statham BN
    Contact Dermatitis; 2006 Jun; 54(6):345. PubMed ID: 16787459
    [No Abstract]   [Full Text] [Related]  

  • 12. Dorzolamide and timolol as suppressors of aqueous humor flow.
    Wegner A; Ugi IA; Harris A
    Arch Ophthalmol; 1998 Aug; 116(8):1133. PubMed ID: 9715706
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carbonic anhydrase inhibitors with topical action in the treatment of glaucomatous diseases. A preliminary note].
    Gafencu O; Armegioiu M; Ionita M
    Oftalmologia; 1997; 41(1):66-8. PubMed ID: 9138500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined therapy in glaucoma treatment: travoprost 0.004% and brinzolamid].
    Popović Suić S; Vukojević N; Cerovski B; Jukić T
    Acta Med Croatica; 2006; 60(2):101-3. PubMed ID: 16848197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local carbonic anhydrase inhibitor dorzolamide: development and properties].
    Pfeiffer N
    Ophthalmologe; 1996 Feb; 93(1):103-18. PubMed ID: 8867167
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans.
    Wayman L; Larsson LI; Maus T; Alm A; Brubaker R
    Arch Ophthalmol; 1997 Nov; 115(11):1368-71. PubMed ID: 9366665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Additive therapy with carboanhydrase inhibitors for open angle glaucoma previously treated with timolol 0.5% drops].
    Kovacić Z; Ivanisević M; Stanić R; Bojić L; Capkun V; Rogosića V
    Acta Med Croatica; 2007 Sep; 61(4):417-9. PubMed ID: 18044479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of a topical carbonic anhydrase inhibitor in patients affected by chronic simple glaucoma.
    D'Andrea A; D'Andrea D; Ferreri G
    Acta Ophthalmol Scand Suppl; 1998; (227):36-8. PubMed ID: 9972339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
    Shin DH; Feldman RM; Sheu WP;
    Ophthalmology; 2004 Feb; 111(2):276-82. PubMed ID: 15019375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.